Pharma’s Puerto Rico problems could mean drug shortages: FDA chief

NEW YORK (Reuters) – The head of the U.S. Food and Drug Administration said on Tuesday the country may start to see a small number of drug shortages within two or three weeks due to delays in restoring manufacturing operations in Puerto Rico, where 10 percent of drugs prescribed in the United States are made.

Leave a Reply

Your email address will not be published. Required fields are marked *